Acupoint Injection of Triamcinolone Acetonide in the Treatment for 35 Patients with Chronic Obstructive Pulmonary Disease at Acute Exacerbation
Zheng Yinshu
Abstract
Zheng Yinshu
Abstract
Objective: To survey the influence of acupoint injection of triamcinolone acetonide on the patients with chronic obstructive pulmonary disease(COPD) at acute exacerbation. Methods: All 68 patients were randomized into two groups, 33 cases of the control group and 35 cases of the treatment group, the control group were administered with routine treatment and the treatment group acupoint injection of triamcinolone acetonide on the foundation of the therapies given to the control group. Curative effects, the changes of blood gas analysis and pulmonary functions were observed. Results: The treatment group was higher than the control group in curative effects(P0.05); PaO2 and PaCO2of both groups were improved after treating compared with before treating(P0.05);the improvements of PaO2 in the treatment group after treating were superior to these of the control group(P0.05);The comparisons showed differences in FEV1% and FEV1/FVC% between before and after treating(P0.05), the comparison had no significant difference in pulmonary function after treating between both groups(P 0.05).Conclusion: Acupoint injection of triamcinolone acetonide is effective in treating COPD patients at acute exacerbation, it could increase blood oxygen and improve clinical symptoms of the patients.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To survey the influence of acupoint injection of triamcinolone acetonide on the patients with chronic obstructive pulmonary disease(COPD) at acute exacerbation. Methods: All 68 patients were randomized into two groups, 33 cases of the control group and 35 cases of the treatment group, the control group were administered with routine treatment and the treatment group acupoint injection of triamcinolone acetonide on the foundation of the therapies given to the control group. Curative effects, the changes of blood gas analysis and pulmonary functions were observed. Results: The treatment group was higher than the control group in curative effects(P0.05); PaO2 and PaCO2of both groups were improved after treating compared with before treating(P0.05);the improvements of PaO2 in the treatment group after treating were superior to these of the control group(P0.05);The comparisons showed differences in FEV1% and FEV1/FVC% between before and after treating(P0.05), the comparison had no significant difference in pulmonary function after treating between both groups(P 0.05).Conclusion: Acupoint injection of triamcinolone acetonide is effective in treating COPD patients at acute exacerbation, it could increase blood oxygen and improve clinical symptoms of the patients.
Key concepts: Medicine, Triamcinolone acetonide, Exacerbation, COPD, Pulmonary function testing, Pulmonary disease, Acetonide, Anesthesia